Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risedronate 150 mg Monthly Micro MRI Study in Osteopenic Women
NCT00577395Phase 4Terminated
- Sponsor
- Warner Chilcott
- Start
- Jul 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of risedronate in osteopenia, osteoporosis, sponsored by Warner Chilcott. Started Jul 2008; status: terminated.
02
Drugs
risedronate
03
Conditions
osteopeniaosteoporosis
Beyond the preview
Go deeper on NCT00577395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00577395.